Jyong Biotech Ltd.
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| – | – | – | – | – | – | |
| – | +10.9% | +0.8% | +3.3% | -5.5% | -16.7% | |
| – | +4,872.0% | +136.3% | -61.9% | -232.9% | – | |
| – | +55.7% | +79.6% | -100.0% | – | – | |
| – | -278.8% | – | -93.2% | – | – | |
| – | – | – | -31.5% | -10.9% | -101.1% | |
| – | -128.2% | – | -39.2% | -1.9% | +786.1% | |
| – | -189.3% | – | -130.9% | – | – | |
| – | – | – | – | – | – |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.